These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19179972

  • 1. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 2. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 3. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.
    Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517
    [Abstract] [Full Text] [Related]

  • 4. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep 30; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 5. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 30; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 6. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
    Takahashi T, Suzuki M, Tanino R, Zhou SY, Hagino H, Niu L, Kawasaki Y, Seto H, Kurachi M.
    Psychiatry Res; 2007 Apr 15; 154(3):209-19. PubMed ID: 17321114
    [Abstract] [Full Text] [Related]

  • 7. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun 15; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003 Jun 15; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 9. Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.
    Chou PH, Koike S, Nishimura Y, Kawasaki S, Satomura Y, Kinoshita A, Takizawa R, Kasai K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar 03; 49():63-9. PubMed ID: 24275075
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
    Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.
    Turk Psikiyatri Derg; 2006 Mar 03; 17(2):85-91. PubMed ID: 16755408
    [Abstract] [Full Text] [Related]

  • 11. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL, Duan HF, Yang JM, Shi ZJ, Zhang DW, Jiang ZK, Gao CY, Wang ZJ.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 22; 91(43):3034-9. PubMed ID: 22333054
    [Abstract] [Full Text] [Related]

  • 12. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.
    Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL.
    Biol Psychiatry; 1998 Feb 15; 43(4):263-9. PubMed ID: 9513735
    [Abstract] [Full Text] [Related]

  • 13. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 15; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 14. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK.
    J Gastroenterol Hepatol; 2008 Jul 15; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [Abstract] [Full Text] [Related]

  • 15. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Siergiejczyk L, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 15; 13 Suppl 1():11-6. PubMed ID: 17507879
    [Abstract] [Full Text] [Related]

  • 16. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.
    Liver Int; 2008 Sep 15; 28(8):1095-103. PubMed ID: 18266634
    [Abstract] [Full Text] [Related]

  • 17. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ.
    Psychiatry Res; 2006 Mar 31; 146(2):127-35. PubMed ID: 16497488
    [Abstract] [Full Text] [Related]

  • 18. [Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates].
    Galińska B, Szulc A, Czernikiewicz A.
    Psychiatr Pol; 2005 Mar 31; 39(5):859-68. PubMed ID: 16358587
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
    Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.
    Psychiatry Clin Neurosci; 2009 Jun 31; 63(3):350-6. PubMed ID: 19566767
    [Abstract] [Full Text] [Related]

  • 20. Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation.
    Wood SJ, Berger GE, Wellard RM, Proffitt TM, McConchie M, Berk M, McGorry PD, Pantelis C.
    Neurobiol Dis; 2009 Mar 31; 33(3):354-7. PubMed ID: 19118629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.